Publication date: Jun 19, 2025

All participants contributed a non-exposure observation time. Subjects with a positive COVID-19 test before DM diagnosis started exposure time at day 31 after the positive sample collection date. Studies suggest an increase in the incidence of chronic conditions post-COVID-19, including neurological and cardiovascular conditions and DM. However, the evidence base for increased DM incidence post-COVID-19 has various limitations. The primary outcome was the time to incident DM, and the exposure was severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These subjects contributed to over 15. 8 million days and 8. 9 million days of pre-exposure and exposure periods, during which 690 and 429 individuals were diagnosed with DM, respectively. These factors may indicate that the magnitude of COVID-19’s impact on diabetes risk may differ in other populations. *Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. COVID-19 was associated with a significantly increased rate of incident DM, with a hazard rate ratio of 1. 17.

Semantics

Original Article